Welcome to our dedicated page for Viemed Healthcare Common Shares news (Ticker: VMD), a resource for investors and traders seeking the latest updates and insights on Viemed Healthcare Common Shares stock.
Viemed Healthcare, Inc. (VMD) is a leading provider of respiratory disease management and medical equipment, focused on enhancing the quality of life for patients with respiratory illnesses. The company’s mission is to educate, nurture, and inspire its patients to lead better lives through a highly effective home treatment model. This model integrates seamlessly with the processes of referral partners to efficiently transition patients from the hospital to their homes or other long-term care settings.
Viemed’s team of respiratory care practitioners, who are trained as COPD educators, deliver therapy and counseling directly to patients in their homes using the most advanced technology available. In parallel, their care consultants collaborate with hospitals, ACOs, SNFs, and other referral sources to simplify the administrative aspects of transitioning patients to home care. This approach has led to industry-leading outcomes in hospital readmissions and patient satisfaction, establishing Viemed as one of the largest providers of home non-invasive ventilation in the United States.
Beyond respiratory disease management, Viemed offers a comprehensive suite of services including neuromuscular care, in-home sleep testing, sleep apnea treatment, oxygen therapy, respiratory equipment rentals, and healthcare staffing services. The company’s revenue primarily comes from medical equipment rental, sales, and supply.
Viemed is continually making strides in its field, as reflected by its regular conference calls where they discuss quarterly and annual financial results. For instance, Viemed will host a conference call to discuss second quarter results on August 10, 2023, third quarter results on November 2, 2023, fourth quarter and year-end results on March 7, 2024, and first quarter results on May 7, 2024. These calls offer an in-depth look at the company's performance and future outlook.
For more information or to access these calls, interested parties can visit the company’s website or contact:
Glen Akselrod
Bristol Capital
905-326-1888
glen@bristolir.com
Todd Zehnder
Chief Operating Officer
Viemed Healthcare, Inc.
337-504-3802
investorinfo@viemed.com
Viemed Healthcare reported strong Q3 2024 financial results with net revenues increasing 17.4% to $58.0 million, setting a company record. Net income rose 33% to $3.9 million ($0.10 per diluted share), while Adjusted EBITDA grew 15.5% to $14.0 million. The company expanded its ventilator patient count by 11.0% to 11,374 and increased sleep therapy patients by 11.0% to 19,478. With a strong cash balance of $11.3 million and $55.3 million available in credit facilities, Viemed projects Q4 2024 revenues between $59.7-60.9 million, exceeding previous guidance.
Viemed Healthcare, a national leader in respiratory care and technology-enabled home medical equipment services, has announced its upcoming third quarter 2024 earnings conference call. The call is scheduled for Thursday, November 7, 2024, at 12:00 p.m. EST.
Interested parties can participate in the call by dialing 877-407-6176 (US Toll-Free) or +1 201-689-8451 (International). A live audio webcast will also be available. Following the live call, a replay will be accessible in the Investor Relations section of Viemed's website at www.viemed.com.
Viemed Healthcare (NASDAQ:VMD) reported record second quarter 2024 financial results, with net revenues reaching $55.0 million, a 27% increase year-over-year and 9% sequential growth. The company achieved a net income of $1.5 million and Adjusted EBITDA of $12.8 million, up 31% from Q2 2023. Viemed's ventilator patient count grew to 10,905, a 4.4% sequential increase. The company maintains a strong financial position with $8.8 million in cash and $13.5 million in working capital. For Q3 2024, Viemed expects net revenues between $56.5 million and $57.7 million. CEO Casey Hoyt emphasized the company's strategy validation and leading position in complex respiratory care services.
Viemed Healthcare, a national leader in respiratory care and technology-enabled home medical equipment services, has announced its upcoming Quarterly Conference Call. The call is scheduled for Thursday, August 8, 2024, at 11:00 a.m. ET.
Interested parties can participate by dialing 888-437-3179 (US Toll-Free) or +1 862-298-0702 (International). Financial professionals are invited to pre-register by emailing investorinfo@viemed.com by 12:00 p.m. ET on Wednesday, August 7, 2024, to ask questions during the call.
A live audio webcast will be available, and following the call, a replay can be accessed in the Investor Relations section of Viemed's website.
Viemed Healthcare, Inc. announced its first quarter 2024 financial results, reporting net revenues of $50.6 million, a 28% increase from the same quarter last year. The company achieved a net income of $1.6 million and adjusted EBITDA of $10.1 million. Viemed also has a strong cash balance of $7.3 million, no net debt, and approximately $53 million available under credit facilities. The recent strategic partnership with East Alabama Health is expected to generate net revenues of $53.8-$54.8 million in the second quarter of 2024. CEO Casey Hoyt expressed optimism about the company's performance, highlighting investments in personnel, operational enhancements, and acquisition strategies.
FAQ
What is the current stock price of Viemed Healthcare Common Shares (VMD)?
What is the market cap of Viemed Healthcare Common Shares (VMD)?
What is Viemed Healthcare, Inc.?
What services does Viemed Healthcare offer?
How does Viemed support patients?
What are the recent achievements of Viemed Healthcare?
How can I participate in Viemed's conference calls?
Who can I contact for more information about Viemed Healthcare?
What is the primary revenue source for Viemed Healthcare?
How does Viemed integrate with its referral partners?
What is Viemed’s approach to respiratory care?
How can I access recordings of Viemed's conference calls?
